Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
2005 1
2006 1
2007 1
2012 2
2014 5
2015 12
2016 11
2017 21
2018 26
2019 22
2020 14
2021 5
2022 8
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Ruëff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Kimball AB, et al. Among authors: uhlmann l. Lancet. 2023 Mar 4;401(10378):747-761. doi: 10.1016/S0140-6736(23)00022-3. Epub 2023 Feb 3. Lancet. 2023. PMID: 36746171 Clinical Trial.
Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists.
Haenssle HA, Fink C, Schneiderbauer R, Toberer F, Buhl T, Blum A, Kalloo A, Hassen ABH, Thomas L, Enk A, Uhlmann L; Reader study level-I and level-II Groups; Alt C, Arenbergerova M, Bakos R, Baltzer A, Bertlich I, Blum A, Bokor-Billmann T, Bowling J, Braghiroli N, Braun R, Buder-Bakhaya K, Buhl T, Cabo H, Cabrijan L, Cevic N, Classen A, Deltgen D, Fink C, Georgieva I, Hakim-Meibodi LE, Hanner S, Hartmann F, Hartmann J, Haus G, Hoxha E, Karls R, Koga H, Kreusch J, Lallas A, Majenka P, Marghoob A, Massone C, Mekokishvili L, Mestel D, Meyer V, Neuberger A, Nielsen K, Oliviero M, Pampena R, Paoli J, Pawlik E, Rao B, Rendon A, Russo T, Sadek A, Samhaber K, Schneiderbauer R, Schweizer A, Toberer F, Trennheuser L, Vlahova L, Wald A, Winkler J, Wölbing P, Zalaudek I. Haenssle HA, et al. Among authors: uhlmann l. Ann Oncol. 2018 Aug 1;29(8):1836-1842. doi: 10.1093/annonc/mdy166. Ann Oncol. 2018. PMID: 29846502 Free article.
Assessing the validity and clinical meaningfulness of skin pain response (NRS30) assessed using numerical rating scale in hidradenitis suppurativa: Results from the SUNSHINE and SUNRISE trials.
Wei X, Passera A, Muscianisi E, Uhlmann L, Chen L, Moreno SG, Martin R, Vandemeulebroecke M, Keefe D, Ravichandran S, Wozniak MB. Wei X, et al. Among authors: uhlmann l. J Am Acad Dermatol. 2023 Dec;89(6):1285-1287. doi: 10.1016/j.jaad.2023.07.1035. Epub 2023 Aug 12. J Am Acad Dermatol. 2023. PMID: 37579844 Free article. No abstract available.
Hypothesis testing in Bayesian network meta-analysis.
Uhlmann L, Jensen K, Kieser M. Uhlmann L, et al. BMC Med Res Methodol. 2018 Nov 12;18(1):128. doi: 10.1186/s12874-018-0574-y. BMC Med Res Methodol. 2018. PMID: 30419827 Free PMC article.
Reply to the letter by Siamak Sabour.
Pretzl B, Uhlmann L. Pretzl B, et al. Among authors: uhlmann l. Acta Odontol Scand. 2017 Aug;75(6):462. doi: 10.1080/00016357.2017.1335432. Epub 2017 Jun 8. Acta Odontol Scand. 2017. PMID: 28593795 No abstract available.
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer.
von Au A, Shencoru S, Uhlmann L, Mayer L, Michel L, Wallwiener M, Hennigs A, Deutsch T, Riedel F, Heil J, Golatta M, Schneeweiss A, Schütz F, Domschke C. von Au A, et al. Among authors: uhlmann l. Arch Gynecol Obstet. 2023 Apr;307(4):1105-1113. doi: 10.1007/s00404-022-06726-7. Epub 2022 Aug 18. Arch Gynecol Obstet. 2023. PMID: 35980458 Free PMC article.
Secukinumab in patients with moderate to severe hidradenitis suppurativa based on prior biologic exposure: An efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Zouboulis CC, Passeron T, Pariser D, Wozniak MB, Li X, Uhlmann L, Lobach I, Martinez AL, Ravichandran S, Alarcon I, Offidani A, Alam MS, Mendes-Bastos P. Zouboulis CC, et al. Among authors: uhlmann l. Br J Dermatol. 2024 Mar 12:ljae098. doi: 10.1093/bjd/ljae098. Online ahead of print. Br J Dermatol. 2024. PMID: 38470171
122 results